Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma

  • STATUS
    Recruiting
  • participants needed
    500
  • sponsor
    Chinese University of Hong Kong
Updated on 7 November 2020
hypertension
intraocular pressure
tension
low tension glaucoma

Summary

To obtain demographic and baseline ophthalmic parameters (such as Intraocular Pressure profiles, disc morphological characteristics, central corneal thickness, peripapillary retinal nerve fibre layer thickness and its serial changes, visual field changes, severity of any medical associations—e.g. hypertension, migraine, strokes, silent cerebral infarcts) with non-invasive measurements, in Chinese Patients with Normal Tension Glaucoma

Description

This is a multi-centered non-interventional descriptive study. The Declaration of Helsinki is followed. All procedures will be conducted in accordance with the GCP guidelines. About 100 Consecutive NTG glaucoma patients will be included in this study. NTG is defined as: 1. Six median untreated intraocular pressure consistently less than 21 mm Hg, with no more than 1 reading = 23 mmHg or 24 mmHg, and with no single measurement greater than 24 mm Hg, 2. Open drainage angles on gonioscopy, 3. Typical optic disc damage with glaucomatous cupping and loss of neuroretinal rim, 4. Absence of any secondary cause for a glaucomatous optic neuropathy (trauma, steroids, uveitis), 5. Glaucomatous visual field defect compatible with glaucomatous optic neuropathy. Age and sex-matched normal control subjects and age, sex, severity-matched POAG control subjects will be recruited. Randomization not required as this will be a non-interventional descriptive study. A complete baseline ophthalmic assessment will be performed with Snellen visual acuity (VA), Best-corrected VA, intraocular pressure (IOP) measurements, slit lamp examination, gonioscopy, disc assessment and dilated fundal examination. These measurements were performed at recruitment and then at 3,6,9,12 months after the intervention. The details of some of these measurements were as follows. All IOP was measured with Goldmann applanation tonometry. The median of 5 readings were taken. Gonioscopy was carried out first using a Goldmann 2-mirror gonioscope. The examination was carried out at the lowest level of illumination that permitted a view of the angle and at high magnification (×16 to ×25). A 1-mm light beam was reduced to a very narrow slit, and was offset horizontally for assessing superior and inferior angles and vertically for nasal and temporal angles. Care was taken to avoid light falling on the pupil during gonioscopy. Slight tilting to gain a view over the convexity of the iris was permitted, but further manipulation of the lens or redirection of gaze was avoided because of the possibility of exerting pressure on the cornea and artificially widening the angle. The drainage angle was graded according to Shaffer's convention in each quadrant. The average angle width was calculated by adding the Shaffer grade in each quadrant and dividing by 4. Indentation gonioscopy using a Posner lens was also used to detect PAS, and the number of clock hours of PAS was recorded. All gonioscopy was performed by a single investigator for standardization. The vertical CDR was taken to be the longest vertical cup diameter divided by the longest vertical disc diameter. Estimates were made to the nearest 0.05. The vertical disc diameter was examined. All features of a glaucomatous optic neuropathy were noted. All subjects underwent static automated white-on-white threshold perimetry (program 24- 2, SITA standard, model 750, Humphrey Instruments, Dublin, CA), and the first reliable VF was used in our analysis. The global indices mean deviation (MD), and pattern standard deviation (PSD) were documented for all cases. After finding the proportion of VF that is reliable, the VF was then scored using the tested scoring algorithm developed for the Advanced Glaucoma Intervention Study (AGIS). Minimal criteria for glaucomatous VF defect were as follows: glaucoma hemifield test outside normal limits, pattern standard deviation with a P value of <5%, or a cluster of ≥3 points in the pattern deviation plot in a single hemifield (superior or inferior) with P value of <5%, one of which must have a P value of <1%. Any one of the preceding criteria, if repeatable, was considered sufficient evidence of a glaucomatous VF defect. Subjects will be verified by diurnal tension curve, which was recorded no more than one year before inclusion in the present study. Systemic haemodynamics Systolic, diastolic, and mean blood pressures (SBP, DBP, MAP) were measured on the upper arm by an automated oscillometric device. Pulse rate (PR) and blood oxygenation was automatically recorded from a finger pulse oximetric device (HP-CMS patient monitor, Hewlett Packard, Palo Alto, CA, USA). Measurement of intraocular pressure (IOP) A Median of 3 readings for each subject with Goldmann applanation tonometer was used for each measurement of intraocular pressure. Fundus Photography and Optical Coherence Tomography (OCT) A baseline fundus photo will be performed for all participants. A baseline OCT for retinal nerve fiber layer thickness and optic nerve head parameters will be determined. Serial changes of these parameters will be correlated to VF indices. Dynamic Contour Tonometry (DCT) and Ocular Response Analyzer (ORA) will also be performed on these subjects. A history of the following systemic conditions was recorded: systemic hypertension (HT), hypotension, ischemic heart disease (IHD), arrhythmia, diabetes mellitus (DM), hypercholesterolemia, cerebral vascular accidents (CVA), migraine, obstructive sleep apnea (OSA), sensorineural hearing loss and Raynaud's phenomenon. All diagnoses were obtained from the history and confirmed by the clinical management system of the Hong Kong Hospital Authority, which is a computerized database connecting all public hospitals and clinics in Hong Kong. Systemic use of statins, beta-blockers, angiotensin-converting-enzyme-inhibitors (ACEI), calcium-channel-blockers, aspirin and diuretics was also noted.

Details
Condition Glaucoma
Clinical Study IdentifierNCT00321386
SponsorChinese University of Hong Kong
Last Modified on7 November 2020

Eligibility

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note